Understanding injury in preterm infants with low oxygen levels
Official title: Systemic Mediators and Biomarkers of Injury in Preterm Infants with Intermittent Hypoxemia
Funded at Ut Southwestern Medical Center · NIH-11228708 · Data updated 2026-11-12
This study is looking at preterm babies who sometimes have low oxygen levels, and it aims to understand what causes harm to them and find new ways to help diagnose and treat these issues, all to improve their health and well-being.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project start | July 12, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $144,188 |
| NIH project number | 7K23HD109471-03 |
| Project ID | NIH-11228708 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are preterm infants who experience episodes of low blood oxygen levels.
✕Less likely to help
Patients who are not preterm or do not experience intermittent hypoxemia may not benefit from this research.
What this research studies
This research focuses on preterm infants who experience intermittent hypoxemia, which are episodes of low blood oxygen levels. The principal investigator, Dr. Elie Abu Jawdeh, aims to learn more about the biological mechanisms that lead to injury in these infants and to identify potential biomarkers that could help in diagnosing and treating these conditions. The research involves a combination of hands-on laboratory work, mentorship, and formal education to develop new treatments for the complications associated with prematurity. By understanding these mechanisms, the research hopes to improve outcomes for vulnerable preterm infants.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic tools and treatments for preterm infants suffering from intermittent hypoxemia.
How similar studies have gone: While there has been significant research on neonatal care, this specific approach to understanding intermittent hypoxemia in preterm infants is relatively novel.
Where this research is happening
-
Ut Southwestern Medical Center
Dallas, United States Active
Researchers
- Principal investigator: Abu Jawdeh, Elie G — Ut Southwestern Medical Center
- Study coordinator: Abu Jawdeh, Elie G
Related research
Other NIH-funded projects on the same topics.
-
Understanding the long-term effects of breathing issues in preterm infants
This study is looking at how short episodes of low oxygen levels in preterm babies might impact their health as they grow up, especially concerning breathing problems like asthma and sleep issues, so we can find ways to help those babies early on for a healthier future.
-
Screening and treatment of Chlamydia infection in pregnancy to help prevent preterm birth
This grant studies whether screening pregnant people for Chlamydia trachomatis and treating those who are positive can reduce the risk of preterm birth.
-
Preterm infant body composition and early-life health after NICU stay
This grant studies how body composition in very preterm babies relates to later brain development and risk of obesity or diabetes, with findings meant to improve care from NICU through early childhood.
-
Brain injury risk in preterm babies with heart disease and how surgery choices affect their brains
This project follows newborns with congenital heart disease born early to understand how their brains are affected and how different surgical approaches might influence outcomes.
-
Xylitol to Prevent Periodontal Disease and Preterm Birth in Pregnancy and Early Childhood
A safe, inexpensive chewable gum approach using xylitol is tested to help pregnant people reduce gum disease and lower the chance of preterm birth and related child health problems.
-
Screening and treatment for Chlamydia infection to help prevent preterm birth
A study in pregnant people will test whether screening for Chlamydia trachomatis and treating it during pregnancy can reduce the risk of babies being born too early.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.